Drugs / SPH7485
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06487455 | Aug 2024 → Dec 2027 expected | neoplasm | Shanghai Pharmaceuticals Holding Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPH7485 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06487455 ↗ |
| Route | Oral | “Orally” NCT06487455 ↗ |